The Motley Fool··Jonathan PoncianoLeMaitre Vascular Surges 30% Despite Insider Sale as Strong Results Drive Confidence
LeMaitre Vascular stock rises 30% annually after Q4 results showed 16% sales growth and 47% operating income gains, despite a senior executive selling $285K in shares.
LMATperipheral vascular diseaseearnings growth